Publicaciones en colaboración con investigadores/as de Universidad de Granada (20)

2022

  1. Guidelines on the management of mineral and bone metabolism disorders during pregnancy and lactation

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 530-539

2020

  1. New technologies in the evaluation of bone fragility and its application in Endocrinology

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 9, pp. 602-610

  2. Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 3, pp. 205-215

2018

  1. Consensus document on osteoporosis in males

    Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 9-16

2017

  1. Recommendations on the effect of antidiabetic drugs in bone

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 1-6

  2. Recommended vitamin D levels in the general population

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 7-14

2012

  1. Fe de errores de "Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales"

    Endocrinologia y Nutricion

1997

  1. Antiresorptive Therapy in Hyperthyroid Patients: Longitudinal Changes in Bone and Mineral Metabolism

    Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 6, pp. 1989-1994

  2. Association between congenital adrenal hyperplasia resulting from 21- hydroxylase deficiency and bilateral testicular tumors: A report of two cases

    Endocrinologist, Vol. 7, Núm. 1, pp. 65-68

  3. Effect of tobacco consumption on bone mineral density in healthy young males

    Calcified Tissue International, Vol. 60, Núm. 6, pp. 496-500

1996

  1. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus

    Calcified Tissue International, Vol. 58, Núm. 5, pp. 316-319

1995

  1. Ketoconazole therapy: Hormonal and clinical effects in non-tumoral hyperandrogenism

    Obstetrical and Gynecological Survey, Vol. 50, Núm. 1, pp. 42-44

1994

  1. Hyperinsulinemia in polycystic ovary syndrome: relationship to clinical and hormonal factors

    The Clinical Investigator, Vol. 72, Núm. 11, pp. 853-857

  2. Letters to the editors [1]

    Clinical Endocrinology

  3. Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome

    Journal of Endocrinological Investigation, Vol. 17, Núm. 8, pp. 647-652

1991

  1. Urinary excretion of digoxin-like immunoreactive factor and arginine-vasopressin in hyper- and hypo-thyroid rats

    Clinical Science, Vol. 81, Núm. 4, pp. 471-476

  2. Urinary excretion of digoxin-like immunoreactive factor and arginine-vasopressin in rats after several osmotic loads

    Life Sciences, Vol. 49, Núm. 8, pp. 611-615

1990

  1. Developement and quality control of a radioimmunoassay for measurement of endogenous digoxin

    Revista española de fisiología, Vol. 46, Núm. 4, pp. 385-391

  2. Measurement of Digoxin-like factor in plasma and urine by radioimmunoassay

    Revista Espanola de Fisiologia, Vol. 46, Núm. 4, pp. 385-392

1989

  1. Effects of K+‐Canrenoate on the Development of DOCA‐salt Hypertension

    Journal of Pharmacy and Pharmacology, Vol. 41, Núm. 5, pp. 335-338